Literature DB >> 20860051

Revisiting an old friend: manganese-based MRI contrast agents.

Dipanjan Pan1, Shelton D Caruthers, Angana Senpan, Ann H Schmieder, Samuel A Wickline, Gregory M Lanza.   

Abstract

Non-invasive cellular and molecular imaging techniques are emerging as a multidisciplinary field that offers promise in understanding the components, processes, dynamics and therapies of disease at a molecular level. Magnetic resonance imaging (MRI) is an attractive technique due to the absence of radiation and high spatial resolution which makes it advantageous over techniques involving radioisotopes. Typically paramagnetic and superparamagnetic metals are used as contrast materials for MR based techniques. Gadolinium has been the predominant paramagnetic contrast metal until the discovery and association of the metal with nephrogenic systemic fibrosis (NSF) in some patients with severe renal or kidney disease. Manganese was one of the earliest reported examples of paramagnetic contrast material for MRI because of its efficient positive contrast enhancement. In this review manganese based contrast agent approaches will be presented with a particular emphasis on nanoparticulate agents. We have discussed both classically used small molecule based blood pool contrast agents and recently developed innovative nanoparticle-based strategies highlighting a number of successful molecular imaging examples.
Copyright © 2010 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20860051      PMCID: PMC3157601          DOI: 10.1002/wnan.116

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  49 in total

Review 1.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light.

Authors:  Tarik F Massoud; Sanjiv S Gambhir
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

2.  MRI sensing based on the displacement of paramagnetic ions from chelated complexes.

Authors:  Tatjana Atanasijevic; Xiao-an Zhang; Stephen J Lippard; Alan Jasanoff
Journal:  Inorg Chem       Date:  2010-03-15       Impact factor: 5.165

3.  In vitro neurotoxicity of magnetic resonance imaging (MRI) contrast agents: influence of the molecular structure and paramagnetic ion.

Authors:  Annabelle Bertin; Anne-Isabelle Michou-Gallani; Jean-Louis Gallani; Delphine Felder-Flesch
Journal:  Toxicol In Vitro       Date:  2010-05-10       Impact factor: 3.500

4.  Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging.

Authors:  Silvio Aime; Lucio Anelli; Mauro Botta; Marino Brocchetta; Simonetta Canton; Franco Fedeli; Eliana Gianolio; Enzo Terreno
Journal:  J Biol Inorg Chem       Date:  2001-07-12       Impact factor: 3.358

5.  Assessment of a potential tumor-seeking manganese metalloporphyrin contrast agent in a mouse model.

Authors:  Yasuo Takehara; Harumi Sakahara; Hatsuko Masunaga; Satoshi Isogai; Nami Kodaira; Masahiro Sugiyama; Hiroyasu Takeda; Tsuneo Saga; Susumu Nakajima; Isao Sakata
Journal:  Magn Reson Med       Date:  2002-03       Impact factor: 4.668

Review 6.  Nephrogenic systemic fibrosis and its impact on abdominal imaging.

Authors:  Martin R Prince; Hong Lei Zhang; Joan C Prowda; Marc E Grossman; David N Silvers
Journal:  Radiographics       Date:  2009-10       Impact factor: 5.333

Review 7.  Gadolinium-based contrast agents and NSF: evidence from animal experience.

Authors:  Martin A Sieber; Thomas Steger-Hartmann; Philipp Lengsfeld; Hubertus Pietsch
Journal:  J Magn Reson Imaging       Date:  2009-12       Impact factor: 4.813

8.  Biological and magnetic contrast evaluation of shape-selective Mn-Fe nanowires.

Authors:  Ken Cham-Fai Leung; Yi-Xiang J Wang; Haohao Wang; Shouhu Xuan; Chun-Pong Chak; Christopher H K Cheng
Journal:  IEEE Trans Nanobioscience       Date:  2009-05-08       Impact factor: 2.935

Review 9.  Nephrogenic systemic fibrosis: history and epidemiology.

Authors:  Henrik S Thomsen
Journal:  Radiol Clin North Am       Date:  2009-09       Impact factor: 2.303

10.  Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.

Authors:  Y Takehara; H Sakahara; H Masunaga; S Isogai; N Kodaira; H Takeda; T Saga; S Nakajima; I Sakata
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

View more
  43 in total

Review 1.  Magnetic nanoparticles in magnetic resonance imaging and diagnostics.

Authors:  Christine Rümenapp; Bernhard Gleich; Axel Haase
Journal:  Pharm Res       Date:  2012-03-06       Impact factor: 4.200

2.  Uptake and retention of manganese contrast agents for PET and MRI in the rodent brain.

Authors:  Christina L Brunnquell; Reinier Hernandez; Stephen A Graves; Ivy Smit-Oistad; Robert J Nickles; Weibo Cai; M Elizabeth Meyerand; Masatoshi Suzuki
Journal:  Contrast Media Mol Imaging       Date:  2016-07-11       Impact factor: 3.161

3.  Safety and Efficacy of A High Performance Graphene-Based Magnetic Resonance Imaging Contrast Agent for Renal Abnormalities.

Authors:  Shruti Kanakia; Jimmy Toussaint; Praveen Kukarni; Stephen Lee; Sayan Mullick Chowdhury; Slah Khan; Sandeep K Mallipattu; Kenneth R Shroyer; William Moore; Balaji Sitharaman
Journal:  Graphene Technol       Date:  2016-08-03

4.  The magnetic, relaxometric, and optical properties of gadolinium-catalyzed single walled carbon nanotubes.

Authors:  Balaji Sitharaman; Barry D Jacobson; Youssef Z Wadghiri; Henry Bryant; Joseph Frank
Journal:  J Appl Phys       Date:  2013-04-04       Impact factor: 2.546

Review 5.  Theragnostic potentials of core/shell mesoporous silica nanostructures.

Authors:  Aswathy Ravindran Girija; Sivakumar Balasubramanian
Journal:  Nanotheranostics       Date:  2019-01-01

6.  Design of Hydrated Porphyrin-Phospholipid Bilayers with Enhanced Magnetic Resonance Contrast.

Authors:  Shuai Shao; Trang Nhu Do; Aida Razi; Upendra Chitgupi; Jumin Geng; Richard J Alsop; Boris G Dzikovski; Maikel C Rheinstädter; Joaquin Ortega; Mikko Karttunen; Joseph A Spernyak; Jonathan F Lovell
Journal:  Small       Date:  2016-10-14       Impact factor: 13.281

7.  Polydisulfide manganese(II) complexes as non-gadolinium biodegradable macromolecular MRI contrast agents.

Authors:  Zhen Ye; Eun-Kee Jeong; Xueming Wu; Mingqian Tan; Shouyu Yin; Zheng-Rong Lu
Journal:  J Magn Reson Imaging       Date:  2011-10-26       Impact factor: 4.813

Review 8.  Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.

Authors:  Emily B Ehlerding; Piotr Grodzinski; Weibo Cai; Christina H Liu
Journal:  ACS Nano       Date:  2018-03-01       Impact factor: 15.881

9.  Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.

Authors:  Manli Song; Ting Liu; Changrong Shi; Xiangzhong Zhang; Xiaoyuan Chen
Journal:  ACS Nano       Date:  2015-12-14       Impact factor: 15.881

10.  Synthesis, Characterization, In Vitro Phantom Imaging, and Cytotoxicity of A Novel Graphene-Based Multimodal Magnetic Resonance Imaging - X-Ray Computed Tomography Contrast Agent.

Authors:  Gaurav Lalwani; Joe Livingston Sundararaj; Kenneth Schaefer; Terry Button; Balaji Sitharaman
Journal:  J Mater Chem B       Date:  2014-06-14       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.